Our Eco-system

It’s an unpredictable world out there with many potential pitfalls and challenges.

There are pharmaceuticals that have greater value than any price that can be put on them. Products that change lives. We believe the best way to protect pharma is with our eco-system of people, solutions, and partners across the world. 

It starts with solutions to prevent pharmaceutical products from being compromised during air transport. It also extends beyond the packaging solution. It entails people who are passionate about securing the safe delivery of pharmaceuticals to the people that depend upon them and that understands and can act based on the local market conditions.

This is why we share our real-life experiences of shipping more than 2,000,000 doses of pharmaceuticals every day with our cold chain partners, covering more than 2,000 pharma trade-lanes across the world. It is also why we have trained more than 16,000 cold chain stakeholders over the past 4 years.

At Envirotainer, our eco-system gives pharmaceutical companies the ability to match their need for risk mitigation and cost, depending on where they are in their product's life-cycle.

Why choose us as your preferred partner?

Ship anywhere in the world

We offer unsurpassable logistics coverage across the world. We have 50+ service stations globally, covering over 300 airports, over 2,000 trade lanes, and have regional operations centers in APAC, EMEA, and Americas.

Learn More

We are where you need us

Global presence means being there when you need us. We provide industry leading market coverage by doing business with over 600+ pharma companies, 100+ airlines, and 40+ forwarders globally. We also have 50+ sales representatives in 20 countries, who can support your specific needs with their local knowledge and expertise. 

Learn More

We're your extended team

We know the cold chain and our staff makes up the backbone of our success. This includes more than 320 employees in 3 regional operations centers, 50+ service stations, Central Operations, and Sales management teams, in-house production facility, and an integrated R&D department.

Learn More

Lease when you need

As we have the largest fleet in the industry, we ship up to 2 million doses of medicine each day, or 140,000 pallets of pharmaceuticals each year. We currently have over 5,800 active temperature-controlled containers in our fleet and it’s growing every day.

Learn More

More benefits:

  • Less packaging (material and time) needed which saves money
  • Eliminated loss and damage which reduces waste and reputational risk
  • The assurance of knowing that products are transported under strictly controlled conditions and within a certain temperature range
  • Shorter time to market which improves the likelihood of successful market entry
  • Fulfillment of increasingly stringent regulations which avoids shipments being delayed by non-compliance
  • An increased insight of where challenges may lie and how to mitigate them to increase predictability of the cold-chain
  • Improved product integrity

Related articles

How to Choose the Right Cold Chain Solution

What is the risk profile of your product? And what are you willing to pay for a safe transport? Is it a low-risk shipment, such as a regular shipment with few challenges, or is it the first shipment at a launch in a new market?

Good Reads #1: What is it like to be in the thick of an NPI?

Pharma cold chain logistics is very complex with many stakeholders involved. We all work hard to ensure that pharmaceuticals maintain optimal quality all the way to the patients. At Envirotainer we believe that the best way to reach our common goal is to improve collaboration and mutual understanding across the logistics chain, we call it our eco-system thinking. Here, we share articles with our network that we think could benefit us all.

7 steps for pharma to protect a New Product Introduction from failure

A New Product Introduction, NPI, is a complex and risky process. Even though approval dates are often not known in advance, transport must take place immediately after approval and must follow the specific requirements of the pharmaceutical. Damaged batches or delays could put the whole product launch at risk and could even have devastating consequences for the company and ultimately the patients. Here are seven steps that quality managers could use as a guide to protect the NPI process and to build operational excellence.

Was this information helpful?